Mesenchymal Stem Cell Content of Human Vertebral Bone Marrow
- 27 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 78 (6) , 925-929
- https://doi.org/10.1097/01.tp.0000133305.81823.2a
Abstract
Mesenchymal stem cells (MSCs) are capable of down-regulating alloimmune responses and promoting the engraftment of hematopoietic stem cells. MSCs may therefore be suitable for improving donor-specific tolerance induction in solid-organ transplantation. Cells from cadaveric vertebral bone marrow (V-BM), aspirated iliac crest-BM, and peripheral blood progenitor cells were compared. Cells were characterized by flow cytometry and colony assays. MSCs generated from V-BM were assayed for differentiation capacity and immunomodulatory function. A median 5.7×108 nucleated cells (NCs) were recovered per vertebral body. The mesenchymal progenitor, colony-forming unit-fibroblast, frequency in V-BM (11.6/105 NC, range: 6.0–20.0) was considerably higher than in iliac crest-BM (1.4/105 NC, range: 0.4–2.6) and peripheral blood progenitor cells (not detectable). MSC generated from V-BM had the typical MSC phenotype (CD105posCD73posCD45negCD34neg), displayed multilineage differentiation potential, and suppressed alloreactivity in mixed lymphocyte reactions. V-BM may be an excellent source for MSC cotransplantation approaches.Keywords
This publication has 9 references indexed in Scilit:
- Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantationTransplantation, 2003
- Current trends in hematopoietic stem cell transplantation in EuropeBlood, 2002
- Therapeutic approaches for transplantationCurrent Opinion in Immunology, 2001
- HEPARINIZED CADAVERIC ORGAN DONORS (HCOD)???A POTENTIAL SOURCE OF HEMATOPOIETIC CELLS FOR TRANSPLANTATION AND GENE THERAPY1Transplantation, 2001
- Mesenchymal stem cells: heading into the clinicBone Marrow Transplantation, 2001
- Analysis of CD34-Expressing Cells in Clinical PracticeVox Sanguinis, 1998
- HEMATOPOIETIC PROGENITOR CELL CONTENT OF VERTEBRAL BODY MARROW USED FOR COMBINED SOLID ORGAN AND BONE MARROW TRANSPLANTATIONTransplantation, 1995
- Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantationThe Lancet, 1994
- Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progenyBlood, 1980